360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

idiopathic

Type: Keyphrase

Name: idiopathic

First reported 1 hour ago - Updated 1 hour ago - 1 reports

Sucampo Pharmaceuticals Inc

Earnings Look Back: Sucampo...

When Sucampo Pharmaceuticals (NASDAQ:SCMP) reported earnings 18 days ago on May 7th, 2013, analysts, on average, expected the company to report a loss of $0.10 on sales of $16.4 million. Sucampo Pharmaceuticals actually reported a loss of $0.08 per share ... [Published Financial News Network online - 1 hour ago]

Entities: Sucampo Pharmaceuticals Inc, Moving Average, idiopathic

First reported 19 hours ago - Updated 19 hours ago - 1 reports

Kyoto University

Findings from Kyoto University Hospital Provide New Insights into Transplantation

(NewsRx) -- By a News Reporter-Staff News Editor at Blood Weekly -- Data detailed on Transplantation have been presented. According to news reporting from Kyoto, Japan, by NewsRx journalists, research stated, "Microchimerism after liver transplantation ... [Published NewsRX - 19 hours ago]

Entities: Kyoto University, Polymerase Chain Reaction, hepatocyte, idiopathic, Kyoto

First reported May 24 2013 - Updated May 24 2013 - 1 reports

Weill Cornell Medical College

Findings on Chronic Inflammatory Demyelinating Polyneuropathy Reported by Investigators at Weill Cornell Medical College

(NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Fresh data on Chronic Inflammatory Demyelinating Polyneuropathy are presented in a new report. According to news reporting originating in New York City, New York, by NewsRx editors, ... [Published NewsRX - May 24 2013]

Entities: Weill Cornell Medical College, plasmapheresis, idiopathic, Corticosteroid, Immunotherapy

First reported May 23 2013 - Updated May 23 2013 - 1 reports

Provocation of an autoimmune response to cardiac voltage-gated sodium channel Na V 1.5 induces cardiac conduction defects in rats

Objective This study tested the hypothesis that inducing an autoimmune response against the cardiac sodium channel (NaV1.5) induces arrhythmias.Background Sporadical evidence supports the concept that autoantibodies may cause cardiac arrhythmias but ... [Published Journal of the American College of Cardiology - May 23 2013]

Entities: Sodium, idiopathic, In Vivo

First reported May 23 2013 - Updated May 23 2013 - 1 reports

Descriptive Epidemiology of Idiopathic Clubfoot

Clubfoot is a common structural malformation, occurring in approximately 1/1,000 live births. Previous studies of sociodemographic and pregnancy‐related risk factors have been inconsistent, with the exception of the strong male preponderance and association ... [Published Bionity.com - May 23 2013]

Entities: idiopathic, Breech birth, Body Mass Index, Amniocentesis, Epidemiology

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Rotigotine

Data on UCB's Neupro Zacks

UCB (UCBJY) recently presented data from a study showing the effect of Neupro on cardiovascular measures in patients with restless legs syndrome (:RLS).The double-blind, placebo-controlled study showed reduction in total nocturnal systolic blood pressure ... [Published Yahoo! Finance - May 22 2013]

Entities: Rotigotine, UCB SA, idiopathic, Patient, gastrointestinal

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Novel Drug Eases Chronic Constipation (CME/CE)

ORLANDO (MedPage Today) -- Plecanatide, a novel agent that mimics the effects of a GI fluid-regulating peptide, was effective on objective measures and patient-rated outcomes in adults with chronic idiopathic constipation, researchers found. ... [Published MedPageToday.com - medical news plus CME for ph ... - May 22 2013]

Entities: Constipation, Drugs, idiopathic

First reported May 22 2013 - Updated May 22 2013 - 1 reports

New Spinal Research Study Findings Have Been Reported by Inv. . .

New Spinal Research Study Findings Have Been Reported by Investigators at Rady Children's HospitalSpinal ResearchNewsRx.comBy a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on Spinal Research have been published. ... [Published Equities.com - May 22 2013]

Entities: idiopathic, Scoliosis, Lippincott Williams & Wilkins, Analysis of Variance, multicenter study

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Two new drugs that help childhood arthritis have been approved

There is better news, it seems for children suffering from JIA( juvenile idiopathic arthitis).An article in the May, 2016 online magazine Arthritis Self-Management,called Two Drugs Approved for Childhood Forms of Arthritis, byCooper B. Wilhelm,... ... [Published Examiner.com - May 22 2013]

Entities: Arthritis, Drugs, idiopathic

First reported May 21 2013 - Updated May 22 2013 - 2 reports

Constipation therapy eases discomfort

Synergy Pharmaceuticals Inc., a New York company with labs in Doylestown, presented positive safety and efficacy results from a multicenter trial of plecanatide in patients with chronic idiopathic constipation (CIC).Synergy is developing plecanatide as ... [Published New York Business Journal - May 21 2013]

Entities: Constipation, Phase III, Gary S Jacob, Synergism

First reported May 21 2013 - Updated May 21 2013 - 1 reports

Gene Linked to Lung Fibrosis and Its Survival (CME/CE)

PHILADELPHIA (MedPage Today) -- A common genetic variant increases the risk of pulmonary fibrosis but also predicts better survival in idiopathic cases, researchers found. ... [Published MedPageToday.com - medical news plus CME for ph ... - May 21 2013]

Entities: fibrosis, idiopathic, Philadelphia (Pennsylvania, United States)

First reported May 21 2013 - Updated May 21 2013 - 1 reports

Toes-knocking out neuropathy

BACKGROUND: Peripheral neuropathy is a disorder of the peripheral nerves, the sensory, motor, and autonomic nerves that connect the spinal cord to skin, muscles, and internal organs. It usually affects the feet and hands. Peripheral neuropathy can ... [Published WFTV - May 21 2013]

Entities: neuropathy, Peripheral Neuropathy, idiopathic, Electrode

Quotes

...According to news reporting from Kyoto, Japan, by NewsRx journalists, research stated, "Microchimerism after liver transplantation is considered to promote graft tolerance or tissue repair, but its significance is controversial. By using multiplex polymerase chain reaction (PCR) of short tandem repeat (STR) loci after laser capture microdissection of hepatocyte nuclei, we compared the proportions of recipient-derived hepatocytes in long-term stable liver allografts and late dysfunctional allografts caused by chronic rejection or idiopathic... We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3."

Findings from Kyoto University Hospital Provide New Insights into Transplantation [Published NewsRX - 19 hours ago]

...According to news reporting originating from Cleveland, Ohio, by NewsRx correspondents, research stated, "To discuss the current combination treatments that involve existing as well as novel drugs that show promise for the treatment of neovascular age-related macular degeneration. Photodynamic therapy in combination with antivascular endothelial growth factor (VEGF) and steroids is currently used as a second-line therapy in patients not responding to monotherapy with anti-VEGF agents or in whom the treatment burden of monthly injections is too great."

New Age-Related Macular Degeneration Findings from Cole Eye Institute Described [Published NewsRX - May 24 2013]

...According to news reporting originating in New York City, New York, by NewsRx editors, the research stated, "Chronic inflammatory demyelinating polyneuropathy (CIDP) is a group of idiopathic, acquired, immune-mediated inflammatory demyelinating diseases of the peripheral nervous system. A majority of patients with CIDP respond to 'first-line' treatment with IVIG, plasmapheresis and/or corticosteroids."

Findings on Chronic Inflammatory Demyelinating Polyneuropathy Reported by Investigators at Weill ... [Published NewsRX - May 24 2013]

"According to yet another aspect of the invention, a method for treating a subject with a below-normal level of gelsolin is provided. The method comprises treating the subject with a first therapy for treating or reducing the risk of a neurologic disease (e g., multiple sclerosis). A level of gelsolin in the subject is obtained. The level of gelsolin is compared to a predetermined value corresponding to a predetermined level of gelsolin (e g., in an apparently healthy control population). If the predetermined level of gelsolin is not reached, the subject is treated with a second agent for treating or reducing the risk of neurologic disease (e g., multiple sclerosis) until the predetermined level of gelsolin is reached."

Patent Issued for Use of Gelsolin to Treat Multiple Sclerosi. . . [Published Equities.com - May 22 2013]

More Content

sort by: Date \| Relevance
Earnings Look Back: Sucampo... [Published Financial News Network online - 1 hour ago]
Does a Pepper a Day Keep Parkinson’s Away? [Published Mercola - 13 hours ago]
Findings from Kyoto University Hospital Provide... [Published NewsRX - 19 hours ago]
Positive Data from Synergy Pharma Zacks [Published Yahoo! Finance - May 24 2013]
New Age-Related Macular Degeneration Findings f... [Published NewsRX - May 24 2013]
Findings on Chronic Inflammatory Demyelinating ... [Published NewsRX - May 24 2013]
FOREST LABORATORIES INC - 10-K - Management's D... [Published Pharmacy Choice - May 24 2013]
Impax Launches Generic Zomig [Published Yahoo! Finance - May 23 2013]
Ironwood Pharma Prices Stock Offering Zacks [Published Yahoo! Finance - May 23 2013]
Abnormal Baseline Brain Activity in Non-Depress... [Published Elites TV - May 23 2013]
PropThink Biotech Stocks to Buy with Big Gains:... [Published 24/7 Wall St - May 23 2013]
Lula Cora Hood story airs in June [Published Galesburg.com - May 23 2013]
Provocation of an autoimmune response to cardia... [Published Journal of the American College of Cardiology - May 23 2013]
Central Serous Chorioretinopathy and Topical NS... [Published Retinal Physician - May 23 2013]
Gene Testing as a Diagnostic Aid in Macular Dis... [Published Retinal Physician - May 23 2013]
Descriptive Epidemiology of Idiopathic Clubfoot [Published Bionity.com - May 23 2013]
Data on UCB's Neupro Zacks [Published Yahoo! Finance - May 22 2013]
Patent Issued for Use of Gelsolin to Treat Mult... [Published Equities.com - May 22 2013]
Novel Drug Eases Chronic Constipation (CME/CE) [Published MedPageToday.com - medical news plus CME for ph ... - May 22 2013]
New Spinal Research Study Findings Have Been Re... [Published Equities.com - May 22 2013]
Losers Recap: Zale Corporation (NYSE:ZLC), Syne... [Published SBWire - May 22 2013]
Two new drugs that help childhood arthritis hav... [Published Examiner.com - May 22 2013]
Synergy Pharma presents plecanatide results fro... [Published India Infoline - May 22 2013]
Synergy Pharmaceuticals Presents Plecanatide Re... [Published Bernama - May 22 2013]
Therapeutic use of anti-CS1 antibodies [Published PharmCast - May 22 2013]
ANYBODY'S MIRACLE [Published Kirkus Reviews - May 22 2013]
4 Healthcare Stock Stories For Tuesday Investme... [Published Wall St. Cheat Sheet - May 21 2013]
Gene Linked to Lung Fibrosis and Its Survival (... [Published MedPageToday.com - medical news plus CME for ph ... - May 21 2013]
Synergy Pharmaceuticals Presents Plecanatide Re... [Published BioSpace - May 21 2013]
Impax calls on former Teva, Watson execs to con... [Published FiercePharma - May 21 2013]

Blogs

sort by: Date \| Relevance
4 Healthcare Stock Stories For Tuesday Investme... [Published Wall St. Cheat Sheet - May 21 2013] Boston Scientific Corporation ( NYSE:BSX ): Closing price $9.23 Five-year data from the Asthma Intervention Research 2 clinical trial presented on Tuesday showed that the Boston Scientific Corporation Alair Bronchial Thermoplasty System continues ...
Nocebo Mass Delusion [Published NeuroLogica Blog - May 09 2013] Expectation bias cuts both ways, for positive and negative expectations. Expectation bias, the tendency to perceive and accept data that reinforces your expectation, is one of the m any contributors to placebo effects (the illusion of a positive benefit ...
ThromboGenics’ JETREA Available in Germany Publ... [Published Pharma-Mag - May 05 2013] ThromboGenics NV, an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, announces that its partner Alcon has launched JETREA in Germany, the second European market where the product is now ...
Breaking News - Opinion Reversing $6.5 Million ... [Published Drug and Device Law - May 02 2013] We saw this morning that the boxcar California verdict that was being ballyhooed the last couple of days was reversed by the trial judge granting a nonsuit (the California equivalent to judgment n.o.v.). But we don't usually discuss verdicts, good or ...
4 Healthcare Stock Stories To Kick Off the Trad... [Published Wall St. Cheat Sheet - Apr 29 2013] Peregrine Pharmaceuticals ( NASDAQ:PPHM ): Closing price $1.41 On Monday, Peregrin reported the completion of patient enrollment in an investigator-sponsored Phase I trial studying bavituximab in combination with the chemotherapeutic agent paclitaxel ...

Press Releases

sort by: Date \| Relevance
Synergy Pharmaceuticals Presents Plecanatide Re... [Published GlobeNewswire: Acquisitions News - May 21 2013]
DGAP-News: Synergy Pharmaceuticals Presents Ple... [Published GlobeNewswire: Acquisitions News - May 21 2013]
Impax Board of Directors Establishes Compliance... [Published Business Wire Science: Science News - May 20 2013]
Impax Board of Directors Establishes Compliance... [Published Business Wire Health News - May 20 2013]
Ironwood and Forest to Present Linaclotide Data... [Published Business Wire - May 14 2013]